Krystal Biotech, Inc. (KRYS) NASDAQ
273.82
-2.116(-0.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
273.82
-2.116(-0.77%)
Currency In USD
| Market Cap | 7.14B |
| Enterprise Value | 6.65B |
| P/E Ratio | 38.69 |
| PEG Ratio | 0.3 |
| Price/Sales Ratio | 20.71 |
| Price/Book Ratio | 6.5 |
| Enterprise/Revenue | 19.46 |
| Enterprise/EBITDA | 45.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.53 |
| Operating Margin | 0.41 |
| Return On Assets | 0.15 |
| Return On Equity | 0.19 |
| Revenue | 389.13M |
| Revenue/Share | 13.44 |
| Gross Profit | 360.36M |
| EBITDA | 167.85M |
| Net Income | 204.83M |
| Diluted EPS | 6.84 |
| Total Cash | 827.79M |
| Total Cash/Share | 28.6 |
| Total Debt | 9.34M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 9.95 |
| Book Value Per Share | 42.14 |
| 52-Week Change | 65.15 |
| 52-Week High | 298.3 |
| 52-Week Low | 122.8 |
| Moving Average 50 Days | 262.89 |
| Moving Average 200 Days | 213.57 |
| Average Volume | 282,367 |
| Shares Outstanding | 29.44M |
| % Held by Institutions | 98.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |